Restructuring of foreign-invested pharmaceutical firms eyed

Published: 2002-12-20 06:59:00

Updated: 2002-12-20 06:59:00

Influenced by the overall business setbacks in the domestic pharmaceutical sector due to debt-ridden finance of the National Health Insurance Corporation and other unfavorable factor in next year, foreign-invested pharmaceutical firms are likely to accelerate their restructuring programs amid the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK